Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 869,086
  • Shares Outstanding, K 26,320
  • Annual Sales, $ 9,540 K
  • Annual Income, $ -72,150 K
  • 60-Month Beta 2.79
  • Price/Sales 90.50
  • Price/Cash Flow N/A
  • Price/Book 3.28
Trade ARCT with:

Options Overview

Details
  • Implied Volatility 82.56%
  • Historical Volatility 55.05%
  • IV Percentile 4%
  • IV Rank 12.32%
  • IV High 146.69% on 10/02/20
  • IV Low 73.54% on 06/17/21
  • Put/Call Vol Ratio 0.45
  • Today's Volume 159
  • Volume Avg (30-Day) 384
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 8,655
  • Open Int (30-Day) 17,746

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -1.99
  • Number of Estimates 6
  • High Estimate -1.22
  • Low Estimate -2.30
  • Prior Year -0.55
  • Growth Rate Est. (year over year) -261.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.20 +21.40%
on 05/26/21
37.00 -10.76%
on 06/14/21
+4.21 (+14.61%)
since 05/21/21
3-Month
24.87 +32.77%
on 05/13/21
45.99 -28.21%
on 03/23/21
-13.20 (-28.56%)
since 03/22/21
52-Week
24.87 +32.77%
on 05/13/21
129.71 -74.54%
on 12/07/20
-7.68 (-18.87%)
since 06/22/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 34.48
2nd Resistance Point 33.84
1st Resistance Point 33.43
Last Price 33.02
1st Support Level 32.38
2nd Support Level 31.74
3rd Support Level 31.33

See More

52-Week High 129.71
Fibonacci 61.8% 89.66
Fibonacci 50% 77.29
Fibonacci 38.2% 64.92
Last Price 33.02
52-Week Low 24.87

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar